|
🐜
|
Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
69 auth.
R. Holloway,
I. Shoulson,
K. Kieburtz,
M. Mcdermott,
P. Tariot,
Cornelia L. Kamp,
D. Day,
A. Shinaman,
S. Fahn,
A. Lang,
K. Marek,
J. Seibyl,
W. Weiner,
M. Welsh,
R. Pahwa,
...
S. Coe,
L. Barclay,
L. Sutherland,
K. Hildebrand,
J. Hubble,
C. Weeks,
P. LeWitt,
J. Miyasaki,
J. Duff,
E. Sime,
O. Suchowersky,
M. Stacy,
M. Kurth,
M. Brewer,
M. Harrigan,
D. Russell,
B. Fussell,
B. Ford,
S. Dillon,
J. Hammerstad,
C. Stone,
D. Riley,
P. Rainey,
D. Standaert,
M. Tennis,
F. Wooten,
E. Rost-ruffner,
S. Factor,
D. Brown,
J. Jankovic,
F. Atassi,
R. Kurlan,
I. Gardiner,
M. Panisset,
D. Amyot,
J. Hall,
A. Rajput,
T. Shirley,
R. Rodnitzky,
J. Dobson,
C. Shults,
D. Fontaine,
C. Waters,
S. Schuman,
R. Pfeiffer,
Shirley A. Rast,
B. Pfeiffer,
A. Brocht,
C. Casaceli,
S. Daigneault,
K. Hodgeman,
K. Honsinger,
C. O'Connell,
A. Watts
|
9 |
2000 |
9
🐜
|
|
🐜
|
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
69 auth.
R. Holloway,
I. Shoulson,
S. Fahn,
K. Kieburtz,
A. Lang,
K. Marek,
M. Mcdermott,
J. Seibyl,
W. Weiner,
B. Musch,
Cornelia L. Kamp,
M. Welsh,
A. Shinaman,
R. Pahwa,
L. Barclay,
...
J. Hubble,
P. LeWitt,
J. Miyasaki,
O. Suchowersky,
M. Stacy,
D. Russell,
B. Ford,
J. Hammerstad,
D. Riley,
D. Standaert,
F. Wooten,
S. Factor,
J. Jankovic,
F. Atassi,
R. Kurlan,
M. Panisset,
A. Rajput,
R. Rodnitzky,
C. Shults,
Giselle Petsinger,
C. Waters,
R. Pfeiffer,
K. Biglan,
Leona D Borchert,
A. Montgomery,
L. Sutherland,
C. Weeks,
M. DeAngelis,
E. Sime,
S. Wood,
C. Pantella,
M. Harrigan,
B. Fussell,
S. Dillon,
Barbara Alexander-Brown,
P. Rainey,
M. Tennis,
E. Rost-ruffner,
Diane L. Brown,
S. Evans,
Debra Berry,
Jean Hall,
T. Shirley,
J. Dobson,
D. Fontaine,
B. Pfeiffer,
A. Brocht,
Susan Bennett,
S. Daigneault,
K. Hodgeman,
C. O'Connell,
Tori Ross,
Karen Richard,
A. Watts
|
9 |
2004 |
9
🐜
|
|
🐜
|
Effect of GPi pallidotomy on motor function in Parkinson's disease
7 auth.
A. Lozano,
A. Lang,
N. Gálvez‐Jiménez,
J. Miyasaki,
J. Duff,
W. Hutchison,
...
J. Dostrovsky
|
9 |
1995 |
9
🐜
|
|
🐜
|
A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study.
90 auth.
A. Siderowf,
M. Stern,
I. Shoulson,
K. Kieburtz,
D. Oakes,
D. Day,
A. Shinaman,
S. Plumb,
S. Fahn,
K. Blindauer,
M. Lew,
H. Hurtig,
M. Lloyd,
R. Hauser,
L. Gauger,
...
L. Golbe,
J. Wojcieszek,
J. Belden,
A. Feigin,
M. Klimek,
Barbara Shannon,
W. Ondo,
C. Hunter,
V. Calabrese,
P. Atchison,
C. Allen,
F. Marshall,
Debra Berry,
I. Gardiner,
J. Miyasaki,
Luisa Del Rizzo,
T. Mendis,
Neila Mendis,
P. Gray,
J. Hubble,
Karen Betcher,
R. Pahwa,
E. Molho,
Diane L. Brown,
L. Shulman,
A. Rajput,
Marianne Ewanishin,
M. Stacy,
Kelli Williamson,
J. Bertoni,
C. Peterson,
P. Tuite,
B. Ebbitt,
K. Shannon,
J. Jaglin,
C. Tanner,
K. Marek,
Karen Stavris,
M. Aminoff,
M. Diminno,
G. Dowling,
U. Kang,
J. Richman,
K. Sethi,
W. Martin,
Pamela King,
G. McInnes,
C. Adler,
P. LeWitt,
M. DeAngelis,
M. Schear,
M. Gordon,
Roberta Winnick,
R. Feldman,
Cathi A Thomas,
K. Conn,
A. Brocht,
C. Chadwick,
Jeannette Connolly,
S. Daigneault,
S. Eberly,
J. Bausch,
L. Josephson,
R. Oliva,
S. Schwid,
A. Lang,
C. Cox,
C. Irvine,
J. Nutt,
W. White,
S. Oren,
R. Levy,
E. Eyal,
D. Ladkani,
W. Houck
|
9 |
2002 |
9
🐜
|
|
🐜
|
Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
12 auth.
D. Simpson,
A. Blitzer,
A. Brashear,
C. Comella,
R. Dubinsky,
M. Hallett,
...
J. Jankovic,
B. Karp,
C. Ludlow,
J. Miyasaki,
M. Naumann,
Y. So
|
9 |
2008 |
9
🐜
|
|
🐜
|
Practice Parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
10 auth.
R. Pahwa,
S. Factor,
Kelly E. Lyons,
W. Ondo,
G. Gronseth,
H. Bronte-Stewart,
...
M. Hallett,
J. Miyasaki,
J. Stevens,
W. Weiner
|
8 |
2006 |
8
🐜
|
|
🐜
|
Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study.
12 auth.
T. Steeves,
T. Steeves,
J. Miyasaki,
M. Zurowski,
A. Lang,
G. Pellecchia,
...
T. Eimeren,
P. Rusjan,
S. Houle,
A. Strafella,
A. Strafella,
A. Strafella
|
8 |
2009 |
8
🐜
|
|
🐜
|
Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease
16 auth.
D. Weintraub,
Staci Hoops,
J. Shea,
K. Lyons,
R. Pahwa,
E. Driver-Dunckley,
C. Adler,
M. Potenza,
J. Miyasaki,
A. Siderowf,
...
J. Duda,
H. Hurtig,
A. Colcher,
S. Horn,
M. Stern,
V. Voon
|
8 |
2009 |
8
🐜
|
|
🐢
|
Prevalence of repetitive and reward-seeking behaviors in Parkinson disease
8 auth.
V. Voon,
K. Hassan,
M. Zurowski,
M. D. Souza,
T. Thomsen,
S. Fox,
...
A. Lang,
J. Miyasaki
|
8 |
2006 |
8
🐢
|
|
🐜
|
A comparison of the mini mental state exam to the montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease
10 auth.
C. Zadikoff,
S. Fox,
D. Tang‐Wai,
T. Thomsen,
R. D. de Bie,
P. Wadia,
...
J. Miyasaki,
Sarah J. Duff-Canning,
A. Lang,
C. Marras
|
8 |
2008 |
8
🐜
|
|
🐜
|
Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease.
9 auth.
V. Voon,
T. Thomsen,
J. Miyasaki,
M. de Souza,
Ariel Shafro,
S. Fox,
...
Sarah J. Duff-Canning,
A. Lang,
M. Zurowski
|
8 |
2007 |
8
🐜
|
|
🐢
|
Prospective prevalence of pathologic gambling and medication association in Parkinson disease
8 auth.
V. Voon,
K. Hassan,
M. Zurowski,
Sarah J. Duff-Canning,
M. D. Souza,
S. Fox,
...
A. Lang,
J. Miyasaki
|
8 |
2006 |
8
🐢
|
